The Effect of Progressive Relaxation and Breathing Exercise on Sleep Quality and Exercise Self-Efficacy in Patients With COPD

COPD Asthma Clinical Trial

Official title:

The Effect of Progressive Relaxation and Breathing Exercise on Sleep Quality and Exercise Self-Efficacy in Patients With COPD

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05397275
• Other study ID #: osmaniye korkut ata university
• Status: Completed
• Phase: N/A
• Start date: February 1, 2021
• Est. completion date: October 1, 2021

Study information

• Verified date: May 2022
• Source: Osmaniye Korkut Ata University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Aim: This study was conducted to determine the effect of progressive muscle relaxation and breathing exercise on sleep quality and exercise self-efficacy in chronic obstructive pulmonary patients. Methods: This study was conducted as a randomized controlled experimental study. The study was conducted with 64 chronic obstructive pulmonary patients, where 36 of them were in the intervention group and 34 in the control group. Data of the study were collected using the descriptive information form, the Pittsburgh Sleep Quality Index, and the Exercise Self-Regulatory Efficacy Scale (Ex-SRES) for patients with COPD. Results: When the total scores pertaining to the sleep quality index and exercise self-efficacy of the individuals in the intervention and control groups were compared, it was found that there were statistically significant differences in the intervention group compared to the control group (p < 0.05). Keywords: Exercise Self-Regulatory Efficacy, sleep quality in patients with COPD, PGE along with breathing exercises, pulmonary rehabilitation

Recruitment information / eligibility

• Status: Completed
• Enrollment: 64
• Est. completion date: October 1, 2021
• Est. primary completion date: July 1, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria:

• were to be 18 years of age or older
• not using sleeping pills
• verbally stating that they have moderate and severe sleep disorders.

Exclusion Criteria:

• having any lung disease other than COPD
• having cardiological problems (heart failure, uncontrollable hypertension, history of angina and myocardial infarction, heart valve problems), psychotic disorder,
• inability to communicate verbally and having hearing problems.

Related Conditions & MeSH terms

• COPD Asthma
• Respiratory Aspiration

Intervention

Other:
• progressive muscle relaxation+breathe exercises
progressive muscle relaxation+breathe exercises
• breathe exercises
breathe exercises

Locations

Country	Name	City	State
Turkey	Aksaray University	Aksaray

Sponsors (1)

Lead Sponsor	Collaborator
Osmaniye Korkut Ata University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	progressive muscle relaxation exercises changes sleep quality and exercise self-efficacy.	Sleep quality will be assessed using the Pittsburgh Sleep Quality Index as an pre- test and 4 weeks later as a post-test test.	1 mounth
Secondary	progressive muscle relaxation exercises with breathing exercise changes sleep quality and exercise self-efficacy.	Sleep quality will be assessed using the Pittsburgh Sleep Quality Index as an pre-test and 4 weeks later as a post-test.; .The Exercise Self-Regulatory Efficacy Scale will be used as a pre-test and after 4 weeks as a post-test to measure the exercise capacity of COPD patients.	1 mounth